AAPL294.09+4.73 (+1.63%) ▲|ABBV250.46-1.18 (-0.47%) ▼|ABT91.99+1.25 (+1.38%) ▲|ACN133.69+9.25 (+7.43%) ▲|ADBE211.66+6.64 (+3.24%) ▲|AMAT642.79-80.22 (-11.09%) ▼|AMD550.87-30.04 (-5.17%) ▼|AMGN358.85-3.27 (-0.90%) ▼|AMT167.08+3.51 (+2.15%) ▲|AMZN244.01+5.67 (+2.38%) ▲|AVGO369.88-7.88 (-2.08%) ▼|AXP348.36+10.11 (+2.99%) ▲|BA217.42+0.95 (+0.44%) ▲|BAC58.31+1.33 (+2.33%) ▲|BKNG184.07+5.83 (+3.27%) ▲|BLK979.29+17.73 (+1.84%) ▲|BMY56.35-1.28 (-2.21%) ▼|BNY146.80+2.19 (+1.51%) ▲|BRK-B502.27+1.88 (+0.38%) ▲|C139.73-0.24 (-0.17%) ▼|CAT995.45-69.45 (-6.52%) ▼|CL92.18+0.50 (+0.55%) ▲|CMCSA24.09-0.47 (-1.89%) ▼|COF203.87+3.25 (+1.62%) ▲|COP103.55-0.41 (-0.39%) ▼|COST925.88-9.60 (-1.03%) ▼|CRM164.60+7.94 (+5.07%) ▲|CSCO116.40-1.06 (-0.90%) ▼|CVS104.62+1.17 (+1.13%) ▲|CVX166.22+0.46 (+0.28%) ▲|DE628.68-5.65 (-0.89%) ▼|DHR193.65+3.17 (+1.66%) ▲|DIS96.53+0.28 (+0.29%) ▲|DUK125.55-1.04 (-0.82%) ▼|EMR140.56-2.60 (-1.81%) ▼|FDX315.06+1.93 (+0.62%) ▲|GD362.21+7.97 (+2.25%) ▲|GE371.57-2.16 (-0.58%) ▼|GEV1,138.85-36.01 (-3.07%) ▼|GILD126.08-0.26 (-0.21%) ▼|GM75.52-1.57 (-2.03%) ▼|GOOG356.07+2.74 (+0.77%) ▲|GOOGL359.17+1.80 (+0.50%) ▲|GS1,024.54+13.17 (+1.30%) ▲|HD353.46+0.78 (+0.22%) ▲|HON220.93-2.97 (-1.33%) ▼|IBM289.18+7.97 (+2.83%) ▲|INTC128.11-11.53 (-8.25%) ▼|INTU270.19+9.19 (+3.52%) ▲|ISRG401.91+4.23 (+1.06%) ▲|JNJ252.47-1.51 (-0.59%) ▼|JPM333.67+6.34 (+1.94%) ▲|KO81.40+0.13 (+0.15%) ▲|LIN536.36+17.42 (+3.36%) ▲|LLY1,175.64-23.79 (-1.98%) ▼|LMT517.91+8.45 (+1.66%) ▲|LOW223.14+2.65 (+1.20%) ▲|LRCX386.96-46.37 (-10.70%) ▼|MA526.21+12.61 (+2.46%) ▲|MCD271.02+0.71 (+0.26%) ▲|MDLZ58.73+0.89 (+1.53%) ▲|MDT78.92+0.69 (+0.88%) ▲|META622.54+59.25 (+10.52%) ▲|MMM160.87-1.04 (-0.64%) ▼|MO72.17+0.22 (+0.30%) ▲|MRK126.10-2.41 (-1.87%) ▼|MS211.85+2.81 (+1.34%) ▲|MSFT387.67+14.65 (+3.93%) ▲|MU1,044.93-109.37 (-9.47%) ▼|NEE86.73-1.04 (-1.18%) ▼|NFLX74.01+2.61 (+3.66%) ▲|NKE42.02+0.97 (+2.35%) ▲|NOW106.39+7.11 (+7.16%) ▲|NVDA198.75-1.35 (-0.67%) ▼|ORCL143.87-2.69 (-1.83%) ▼|PEP140.59+5.19 (+3.83%) ▲|PFE23.80-0.29 (-1.18%) ▼|PG146.10-0.54 (-0.37%) ▼|PLTR127.54+10.87 (+9.32%) ▲|PM179.59-1.32 (-0.73%) ▼|QCOM183.81-0.98 (-0.53%) ▼|RTX190.13+0.40 (+0.21%) ▲|SBUX103.42+1.23 (+1.20%) ▲|SCHW95.82+3.55 (+3.84%) ▲|SO95.23-0.48 (-0.50%) ▼|SPG221.12-2.53 (-1.13%) ▼|T20.64-0.06 (-0.28%) ▼|TMO514.97+13.61 (+2.71%) ▲|TMUS173.29+5.56 (+3.31%) ▲|TSLA426.19+5.59 (+1.33%) ▲|TXN299.13+1.06 (+0.36%) ▲|UBER73.24+1.08 (+1.50%) ▲|UNH425.67+10.04 (+2.42%) ▲|UNP278.20+6.20 (+2.28%) ▲|UPS110.08+2.58 (+2.40%) ▲|USB62.07+1.67 (+2.76%) ▲|V351.73+8.64 (+2.52%) ▲|VZ42.02-0.33 (-0.77%) ▼|WFC85.52+2.88 (+3.49%) ▲|WMT108.33-4.93 (-4.35%) ▼|XOM136.32-0.40 (-0.29%) ▼|AAPL294.09+4.73 (+1.63%) ▲|ABBV250.46-1.18 (-0.47%) ▼|ABT91.99+1.25 (+1.38%) ▲|ACN133.69+9.25 (+7.43%) ▲|ADBE211.66+6.64 (+3.24%) ▲|AMAT642.79-80.22 (-11.09%) ▼|AMD550.87-30.04 (-5.17%) ▼|AMGN358.85-3.27 (-0.90%) ▼|AMT167.08+3.51 (+2.15%) ▲|AMZN244.01+5.67 (+2.38%) ▲|AVGO369.88-7.88 (-2.08%) ▼|AXP348.36+10.11 (+2.99%) ▲|BA217.42+0.95 (+0.44%) ▲|BAC58.31+1.33 (+2.33%) ▲|BKNG184.07+5.83 (+3.27%) ▲|BLK979.29+17.73 (+1.84%) ▲|BMY56.35-1.28 (-2.21%) ▼|BNY146.80+2.19 (+1.51%) ▲|BRK-B502.27+1.88 (+0.38%) ▲|C139.73-0.24 (-0.17%) ▼|CAT995.45-69.45 (-6.52%) ▼|CL92.18+0.50 (+0.55%) ▲|CMCSA24.09-0.47 (-1.89%) ▼|COF203.87+3.25 (+1.62%) ▲|COP103.55-0.41 (-0.39%) ▼|COST925.88-9.60 (-1.03%) ▼|CRM164.60+7.94 (+5.07%) ▲|CSCO116.40-1.06 (-0.90%) ▼|CVS104.62+1.17 (+1.13%) ▲|CVX166.22+0.46 (+0.28%) ▲|DE628.68-5.65 (-0.89%) ▼|DHR193.65+3.17 (+1.66%) ▲|DIS96.53+0.28 (+0.29%) ▲|DUK125.55-1.04 (-0.82%) ▼|EMR140.56-2.60 (-1.81%) ▼|FDX315.06+1.93 (+0.62%) ▲|GD362.21+7.97 (+2.25%) ▲|GE371.57-2.16 (-0.58%) ▼|GEV1,138.85-36.01 (-3.07%) ▼|GILD126.08-0.26 (-0.21%) ▼|GM75.52-1.57 (-2.03%) ▼|GOOG356.07+2.74 (+0.77%) ▲|GOOGL359.17+1.80 (+0.50%) ▲|GS1,024.54+13.17 (+1.30%) ▲|HD353.46+0.78 (+0.22%) ▲|HON220.93-2.97 (-1.33%) ▼|IBM289.18+7.97 (+2.83%) ▲|INTC128.11-11.53 (-8.25%) ▼|INTU270.19+9.19 (+3.52%) ▲|ISRG401.91+4.23 (+1.06%) ▲|JNJ252.47-1.51 (-0.59%) ▼|JPM333.67+6.34 (+1.94%) ▲|KO81.40+0.13 (+0.15%) ▲|LIN536.36+17.42 (+3.36%) ▲|LLY1,175.64-23.79 (-1.98%) ▼|LMT517.91+8.45 (+1.66%) ▲|LOW223.14+2.65 (+1.20%) ▲|LRCX386.96-46.37 (-10.70%) ▼|MA526.21+12.61 (+2.46%) ▲|MCD271.02+0.71 (+0.26%) ▲|MDLZ58.73+0.89 (+1.53%) ▲|MDT78.92+0.69 (+0.88%) ▲|META622.54+59.25 (+10.52%) ▲|MMM160.87-1.04 (-0.64%) ▼|MO72.17+0.22 (+0.30%) ▲|MRK126.10-2.41 (-1.87%) ▼|MS211.85+2.81 (+1.34%) ▲|MSFT387.67+14.65 (+3.93%) ▲|MU1,044.93-109.37 (-9.47%) ▼|NEE86.73-1.04 (-1.18%) ▼|NFLX74.01+2.61 (+3.66%) ▲|NKE42.02+0.97 (+2.35%) ▲|NOW106.39+7.11 (+7.16%) ▲|NVDA198.75-1.35 (-0.67%) ▼|ORCL143.87-2.69 (-1.83%) ▼|PEP140.59+5.19 (+3.83%) ▲|PFE23.80-0.29 (-1.18%) ▼|PG146.10-0.54 (-0.37%) ▼|PLTR127.54+10.87 (+9.32%) ▲|PM179.59-1.32 (-0.73%) ▼|QCOM183.81-0.98 (-0.53%) ▼|RTX190.13+0.40 (+0.21%) ▲|SBUX103.42+1.23 (+1.20%) ▲|SCHW95.82+3.55 (+3.84%) ▲|SO95.23-0.48 (-0.50%) ▼|SPG221.12-2.53 (-1.13%) ▼|T20.64-0.06 (-0.28%) ▼|TMO514.97+13.61 (+2.71%) ▲|TMUS173.29+5.56 (+3.31%) ▲|TSLA426.19+5.59 (+1.33%) ▲|TXN299.13+1.06 (+0.36%) ▲|UBER73.24+1.08 (+1.50%) ▲|UNH425.67+10.04 (+2.42%) ▲|UNP278.20+6.20 (+2.28%) ▲|UPS110.08+2.58 (+2.40%) ▲|USB62.07+1.67 (+2.76%) ▲|V351.73+8.64 (+2.52%) ▲|VZ42.02-0.33 (-0.77%) ▼|WFC85.52+2.88 (+3.49%) ▲|WMT108.33-4.93 (-4.35%) ▼|XOM136.32-0.40 (-0.29%) ▼|
33.9 C
New York
Wednesday, July 1, 2026

Tag: research

newssourceFORcompanyinformationcontent1releasesmarket

AKAMAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

Second quarter revenue of $1.043 billion, up 7% year-over-year and up 6% when adjusted for foreign exchange* Cloud Infrastructure Services** revenue of $71 million, up 30% year-over-year...

Arctic Pablo Coin Opens Final Presale Stage After Raising $3.25M and Burning Over 11.1 Billion Tokens

LONDON, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Arctic Pablo Coin ($APC), a blockchain-based meme coin project, has officially entered Stage 35, marking the final round of its presale. With over $3.25 million raised and 11.123 billion tokens burned to date, the project is preparing for its upcoming launch on centralized and decentralized exchanges.

Dogwood Therapeutics Announces Enrollment of First Fifty Patients in Ongoing Halneuron® Phase 2b Trial

- Halneuron® Chemotherapy-Induced Neuropathic Pain (“CINP”) Phase 2b study interim data readout remains on track as projected for Q4 2025 -

Quantiphi Achieves Google Cloud Data Management Specialization

MARLBOROUGH, Mass., Aug. 7, 2025 /PRNewswire/ -- Quantiphi, an AI-first digital engineering company, today announced it has achieved the Google Cloud Partner Advantage Specialization...

Faster and Safer: XXKK Exchange Launches Fully Upgraded Web Platform, Delivering Smart Crypto Trading Experience in 2025

DENVER, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Leading cryptocurrency trading platform XXKK Exchange officially announces the launch of its fully upgraded web trading platform. This upgrade centers on enhancing user experience across key areas including account registration, KYC verification, crypto trading operations, digital asset management, security, and customer support. The new platform significantly improves the efficiency and safety of trading major cryptocurrencies such as Bitcoin, USDT, and Ethereum, empowering users to manage their digital assets smarter and more conveniently.

Chain Transfer Agents Market to Hit USD 365 Million by 2031, Driven by Polymer Demand Surge | Valuates Reports

BANGALORE, India, Aug. 7, 2025 /PRNewswire/ -- What is the Market Size of Chain Transfer Agents Market? The global market for Chain Transfer Agents was valued...

Chain Transfer Agents Market to Hit USD 365 Million by 2031, Driven by Polymer Demand Surge | Valuates Reports

BANGALORE, India, Aug. 7, 2025 /PRNewswire/ -- ...

ALMORA BOTANICA GRANTED TWO GROUNDBREAKING PATENTS

A New Era of Ayurvedic Skincare Innovation LONDON, Aug. 7, 2025 /PRNewswire/ -- Almora Botanica, the pioneering science-first Ayurvedic skincare brand, has secured two groundbreaking...

Rubicon Point Partners Announces First Close of Rubicon Point Fund II

Rubicon Point Partners closed Fund II, a property-agnostic real estate fund targeting special situations across the West Coast, focused on the SF Bay Area.

BDC Laboratories Partners with Newly Launched Dilawri Cardiovascular Institute to Advance Clinically Relevant Cardiovascular Device Testing

Strategic collaboration supports cutting-edge translational research, combining regulatory-grade bench testing with clinical insight to improve outcomes for patients. WHEAT RIDGE, Colo. and VANCOUVER, BC, Aug....

BDC Laboratories Partners with Newly Launched Dilawri Cardiovascular Institute to Advance Clinically Relevant Cardiovascular Device Testing

Strategic collaboration supports cutting-edge translational research, combining regulatory-grade bench testing with clinical insight to improve outcomes for patients. WHEAT RIDGE, Colo. and VANCOUVER, BC, Aug....

Armyworms Threaten Texas Lawns: Dr. Green Services Responds to Rapid Outbreak in DFW Area

DALLAS and FORT WORTH, Texas, Aug. 7, 2025 /PRNewswire/ -- Dr. Green Services has issued an urgent alert for homeowners across North Texas as...

Locksley Appoints Tribeca Capital to Support U.S. Critical Minerals Growth Strategy Strategy

SAN BERNARDINO, Calif., Aug. 7, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it has appointed Tribeca Capital Pte. Ltd. (Tribeca...

Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 14, 2025

FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that the Company will report financial results for the second quarter ended June 30, 2025, and provide a corporate update on August 14, 2025, at 8:30 a.m. Eastern Time.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsResearch

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers